台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    73.8
  • 漲跌
    ▲0.4
  • 漲幅
    +0.54%
  • 成交量
    1,214
  • 產業
    上櫃 生技醫療類股
  • 321人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
中裕 (4147)籌碼相關-永豐金-新竹 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1202/2403/0603/1803/2804/1004/1260708090100110120May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

永豐金-新竹 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/10173.4000.0073.4012,3720.04%
2025/04/08071.606071.5071.30-602,331-2.57%
2025/03/31190.5000.0088.0012,2770.04%
2025/03/28194.8000.0093.8012,2570.04%
2025/03/2500.00198.0098.60-12,210-0.05%
2025/03/2000.00194.8095.80-12,123-0.05%
2025/03/18091.8000.0091.9002,0850.00%
2025/03/13592.9800.0091.6052,0990.24%
2025/03/1200.00197.7097.50-12,060-0.05%
2025/03/112.195.9000.0095.602.12,0410.10%
2025/03/1000.00197.9097.80-12,016-0.05%
2025/03/072.197.69198.3096.501.11,9910.05%
2025/02/270.196.3000.0095.500.11,8780.01%
2025/02/26099.0000.0098.0001,8860.00%
2025/02/253100.476101.1599.30-31,856-0.16%
2025/02/24899.554102.3899.3041,7960.22%
2025/02/218101.742100.1098.9061,7270.35%
2025/02/20198.60396.6099.70-21,553-0.13%
2025/02/192.194.7200.0095.202.11,5100.14%
2025/02/18294.25293.7094.0001,4910.00%
2025/02/1780101.4371107.2897.1091,4400.62%
2025/02/1400.00199.2098.90-11,226-0.08%
2025/02/1200.001.593.1093.00-1.51,152-0.13%
2025/02/11092.00190.6091.70-11,140-0.09%
2025/02/10189.5000.0089.9011,1290.09%
2025/02/07187.40189.3090.1001,1250.00%
2025/01/17085.9000.0084.6001,1310.00%
2025/01/14188.4000.0087.3011,1470.09%
2025/01/13289.90291.5589.9001,1320.00%
2025/01/1000.00187.8090.50-11,064-0.09%
2025/01/09289.201.290.4287.500.81,0140.08%
2025/01/08499.984.599.3697.20-0.5872-0.06%
2025/01/07190.5000.0092.7016490.15%
2025/01/0600.00190.4089.80-1611-0.16%
2025/01/02787.640.587.4087.006.55911.10%
2024/12/260.584.50184.5086.30-0.5592-0.08%
2024/12/25183.5000.0083.9015890.17%
2024/12/2400.00283.8082.90-2597-0.33%
2024/12/23182.90184.7082.9006120.00%
2024/12/17182.2000.0082.0016250.16%
2024/12/106287.7000.0087.506261510.08%
2024/12/06288.25389.2787.60-1573-0.17%
2024/11/26084.1000.0083.9005390.00%
2024/11/2200.00180.6079.90-1512-0.20%
2024/11/2100.00180.0079.70-1511-0.20%
2024/11/18279.2000.0078.7025340.37%
2024/11/11179.80181.7082.4005330.00%
2024/10/3000.00183.0081.40-1601-0.17%
2024/10/28181.50184.1081.0005840.00%
2024/10/2400.00182.5080.80-1572-0.17%
2024/10/23180.70182.0081.8005700.00%
2024/10/1700.00175.0075.00-1591-0.17%
2024/10/15074.5000.0074.2006100.00%
2024/10/08177.1900.0076.3016180.16%
2024/10/07077.8000.0077.8006290.00%
2024/09/30180.00180.8079.7006420.00%
2024/09/27180.2000.0080.1016490.15%
2024/09/25281.70283.9082.2006510.00%
2024/09/18081.60180.6081.40-1665-0.15%
2024/09/12179.7000.0079.8016820.15%
2024/09/09178.60180.3080.6006970.00%
2024/09/0600.00180.1080.20-1702-0.14%
2024/09/05179.2000.0079.2017110.14%
2024/09/04181.5000.0081.3017420.13%
2024/08/2900.00184.4084.40-1734-0.14%
2024/08/28084.2000.0083.7007330.00%
2024/08/22081.0000.0081.3007590.00%
2024/08/16080.2000.0080.9007530.00%
2024/08/1500.00180.0080.00-1775-0.13%
2024/08/0800.00175.5076.70-1783-0.13%
2024/08/0700.00173.8075.60-1779-0.13%
2024/08/06269.4000.0070.3027710.26%
2024/08/05174.5000.0074.0017340.14%
2024/07/29083.80783.5482.60-7741-0.94%
2024/07/23286.8500.0086.5027460.27%
2024/07/2200.00289.5087.10-2745-0.27%
2024/07/19288.40189.8086.5017270.14%
2024/07/02189.0000.0088.6019920.10%
2024/07/0100.001.390.1590.20-1.31,096-0.12%
2024/06/28189.20190.2089.3001,1030.00%
2024/06/27189.6000.0089.4011,1190.09%
2024/06/2600.001.588.7789.50-1.51,123-0.13%
2024/06/1900.00089.5089.5001,1360.00%
2024/06/180.291.9700.0092.000.21,1400.02%
2024/06/170.192.0000.0091.500.11,1530.01%
2024/06/1400.00490.8090.90-41,158-0.35%
2024/06/13191.0000.0091.0011,1640.09%
2024/06/12391.9300.0091.0031,1740.26%
2024/06/11192.10192.8091.0001,1820.00%
2024/06/06090.3000.0089.4001,1960.00%
2024/06/0500.00290.1090.30-21,237-0.16%
2024/06/04089.40689.5089.50-61,317-0.45%
2024/05/3100.00189.2090.10-11,420-0.07%
2024/05/3000.00189.0088.60-11,475-0.07%
2024/05/2900.00290.9089.10-21,511-0.13%
2024/05/2700.00087.7087.5001,7010.00%
2024/05/2300.00187.1087.10-12,014-0.05%
2024/05/21389.6700.0088.0032,1230.14%
2024/05/1700.00187.8087.70-12,170-0.05%
2024/05/15186.8000.0086.4012,2110.05%
2024/05/1400.00188.5087.40-12,250-0.04%
2024/05/08086.8000.0086.7002,3350.00%
2024/05/07287.7500.0086.7022,3360.09%
2024/05/03186.00285.8585.80-12,318-0.04%
2024/05/02184.7000.0085.0012,3210.04%
2024/04/30285.1000.0085.5022,3290.09%
2024/04/2900.001384.8786.00-132,338-0.56%
2024/04/26183.3000.0083.0012,3240.04%
2024/04/25283.2500.0082.5022,3250.09%
2024/04/24183.403.384.3084.80-2.32,321-0.10%
2024/04/23382.80383.3782.8002,3280.00%
2024/04/22183.50783.8781.80-62,329-0.26%
2024/04/1900.003183.2783.10-312,334-1.33%
2024/04/17188.50187.9087.8002,3560.00%
2024/04/15391.70192.8090.1022,3420.09%
〈美對等關稅〉中裕回應暫無影響 愛滋病新藥足以供應美國市場銷售Anue鉅亨-4天前
中裕長效愛滋療法主要指標達標 啟動國際授權合作Anue鉅亨-18天前
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕 相關文章